Turmeric extract tested as Last-Ditch hope for tough colon cancers
NCT ID NCT02724202
Summary
This small, early-stage study tested whether adding the dietary supplement curcumin (from turmeric) to standard chemotherapy could help control metastatic colon cancer that had stopped responding to chemotherapy alone. Researchers aimed to check if the combination was safe and if it showed any signs of slowing cancer growth in 15 patients. The study also looked for changes in blood markers that might indicate whether the treatment was having an effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Charles A. Sammons Cancer Center
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.